70 related articles for article (PubMed ID: 2355603)
1. [Clinical significance of natural killer cell activity].
Abo T
Nihon Rinsho; 1990 Feb; 48 Suppl():726-9. PubMed ID: 2355603
[No Abstract] [Full Text] [Related]
2. In vivo Epstein Barr virus-induced augmentation of natural killer cell activity in the Chédiak-Higashi syndrome.
Katz P; Zaytoun AM; Lee JH; Fauci AS
J Immunol; 1984 Feb; 132(2):571-3. PubMed ID: 6197464
[No Abstract] [Full Text] [Related]
3. Characterization of a murine model (beige) for a natural killer cell immunodeficiency in the Chediak-Higashi syndrome of man.
Roder JC
Prog Clin Biol Res; 1982; 94():315-25. PubMed ID: 7122620
[No Abstract] [Full Text] [Related]
4. [Chediak-Higashi syndrome in an adult female].
Utsunomiya A; Saito T; Hanada S; Tin E; Oshige T; Hashimoto S; Hamaguchi Y; Ueno T
Rinsho Ketsueki; 1988 Sep; 29(9):1422-6. PubMed ID: 3216514
[No Abstract] [Full Text] [Related]
5. Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia.
Vilmer E; Lenoir GM; Virelizier JL; Griscelli C
Clin Exp Immunol; 1984 Feb; 55(2):249-56. PubMed ID: 6321070
[TBL] [Abstract][Full Text] [Related]
6. The "lazy" NK cells of Chediak-Higashi syndrome.
Targan SR; Oseas R
J Immunol; 1983 Jun; 130(6):2671-4. PubMed ID: 6602174
[TBL] [Abstract][Full Text] [Related]
7. Altered lectin-mediated cytotoxicity in Chédiak-Higashi syndrome patients.
Merino F; Rodríguez F; Biondo-Bracho M; Amesty C; Ramírez-Duque P
Clin Immunol Immunopathol; 1984 Nov; 33(2):139-43. PubMed ID: 6333304
[No Abstract] [Full Text] [Related]
8. Further studies of natural killer cell function in Chediak-Higashi patients.
Roder JC; Haliotis T; Laing L; Kozbor D; Rubin P; Pross H; Boxer LA; White JG; Fauci AS; Mostowski H; Matheson DS
Immunology; 1982 Jul; 46(3):555-60. PubMed ID: 6212535
[TBL] [Abstract][Full Text] [Related]
9. Phytohemagglutinin as a skin test for the evaluation of cellular immune competence in man.
Blaese RM; Weiden P; Oppenheim JJ; Waldmann TA
J Lab Clin Med; 1973 Apr; 81(4):538-48. PubMed ID: 4696186
[No Abstract] [Full Text] [Related]
10. Natural killer cells.
Kay NE
Crit Rev Clin Lab Sci; 1986; 22(4):343-59. PubMed ID: 2419034
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell activity in a patient with Chédiak-Higashi syndrome submitted to bone marrow transplantation.
Diamond HR; Souza MH; Silva ML; Tabak DG; Ferman S; M-Silva VM; de La Rocque L; Rumjanek VM
Pediatr Hematol Oncol; 1995; 12(4):399-402. PubMed ID: 7577393
[No Abstract] [Full Text] [Related]
12. Defects of immune interferon secretion and natural killer activity in patients with immunological disorders.
Virelizier JL; Lipinski M; Tursz T; Griscelli C
Lancet; 1979 Sep; 2(8144):696-7. PubMed ID: 90787
[No Abstract] [Full Text] [Related]
13. [Interferon and natural killer cells].
Saksela E
Duodecim; 1980; 96(16):1061-4. PubMed ID: 6164530
[No Abstract] [Full Text] [Related]
14. Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus.
Oshimi K; Gonda N; Sumiya M; Kano S
Clin Exp Immunol; 1980 Apr; 40(1):83-8. PubMed ID: 7389219
[TBL] [Abstract][Full Text] [Related]
15. [In vitro augmentation of human natural killer cell activity by pokeweed mitogen-stimulated lymphocytes].
Matsumoto Y; Katoh Y
Rinsho Byori; 1983 Oct; 31(10):1122-6. PubMed ID: 6674584
[No Abstract] [Full Text] [Related]
16. Reversal of natural killer defect in a patient with Chédiak-Higashi syndrome after bone-marrow transplantation.
Virelizier JL; Lagrue A; Durandy A; Arenzana F; Oury C; Griscelli C; Reinert P
N Engl J Med; 1982 Apr; 306(17):1055-6. PubMed ID: 7038504
[No Abstract] [Full Text] [Related]
17. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus.
Ewan PW; Barrett HM; Pusey CD
J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577
[TBL] [Abstract][Full Text] [Related]
18. [Natural cytotoxicity in systemic lupus erythematosus patients].
Aleksandrova EN; Nasonov EL; Bykhovskaia SIu; Ivanova MM; Solov'ev SK
Ter Arkh; 1984; 56(5):29-32. PubMed ID: 6463883
[No Abstract] [Full Text] [Related]
19. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
[TBL] [Abstract][Full Text] [Related]
20. Chediak-Higashi syndrome natural killer cells: a protein kinase C defective activation/regulation defect?
Merino F; Esparza B; Sabino E
Eur J Pediatr; 1996 Mar; 155(3):254. PubMed ID: 8929738
[No Abstract] [Full Text] [Related]
[Next] [New Search]
